en

PRODUCT DETAIL

Jansitin Duo 50 mg/850 mg filmom obalené tablety

Code 2695E
MA number 18/0014/23-S
Product Form: tbl flm 200x50 mg/850 mg (blis.PVC/PVDC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: G.L. Pharma GmbH, Austria
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BD Combinations of oral blood glucose lowering drugs
A10BD07 Metformin and sitagliptin
Shelf life: 24
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 25.01.2023
Validity: 25.01.2028
SPC: SPC_Jansitin Duo 50 mg_850 mg_01_2023.pdf  
PIL: PIL_Jansitin Duo 50 mg_850 mg_01_ 2023.pdf  
Safety feature Yes
Data update: 26.01.2023
eu-flag.png sk-flag.png